Urinary arsenic excretion as a biomarker of arsenic exposure in children

Archives of Environmental Health

Volumn 52, Issue 2, 1997, Pages 139-147

  Hwang, Yaw Huei ^a   Bornschein, Robert L ^b   Grote, Joann ^b   Menrath, William ^b   Roda, Sandy ^b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC;

ARTICLE; CANADA; CANCER; CANCER RISK; DIAGNOSTIC VALUE; DRUG URINE LEVEL; ENVIRONMENTAL EXPOSURE; HUMAN; PRIORITY JOURNAL; SMELTER; SOIL POLLUTION;

EID: 0030892237     PISSN: 00039896     EISSN: None     Source Type: Journal    
DOI: 10.1080/00039899709602878     Document Type: Article

References (38)

1. Enterline PE, Marsh GM, Esmen NA, et al. Some effects of cigarette smoking, arsenic, and S02 on mortality among US copper smelter workers. J Occup Med 1987; 29(10):831-38.
2. Lee-Feldstein A. A comparison of several measures of exposure to arsenic. Am J Epidemiol 1989; 129:112-24.
3. Enterline PE, Henderson VL, Marsh GM. Exposure to arsenic and respiratory cancer-a reanalysis. Am J Epidemiol 1987; 125: 929-38.
4. Smith AH, Hopenhayn-Rich C, Bates MN, et al. Cancer risks from arsenic in drinking water. Environ Health Perspect 1992; 97:259-67.
5. Roat JW, Wald A, Mendelow H, Pataki Kl. Hepatic angiosarcoma associated with short-term arsenic ingestion. Am J Med 1982; 73: 933-36.
6. Zaldivar R, Prumes L, Ghai GL. Arsenic dose in patients with cutaneous carcinomata and hepatic haemangio-endothelioma after environmental and occupational exposure. Arch Toxicol 1981;47:145-54.
7. Chen CJ, Kuo TL, Wu MM. Arsenic and cancers. Lancet 1988; 1:414-15.
8. Wu MM, Kuo TL, Hwang YH, Chen CJ. Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases. Am J Epidemiol 1989; 130:1123-32.
9. Risk Assessment Forum. Special report on ingested arsenic. Skin Cancer: Nutritional Essentiality. Washington, DC: US Environmental Protection Agency, 1988; EPA/625/3-87/013.
10. Chen CJ, Chuang YC, You SL, et al. A retrospective study on malignant neoplasms of bladder, lung and liver in Blackfoot Disease endemic area in Taiwan. Br J Cancer 1986; 53:399-405.
11. Crecelius EA. Changes in the chemical speciation of arsenic following ingestion by man. Environ Health Perspect 1977; 19:147-50.
12. Tam GKH, Charbonneau SM, Bryce F, et al. Metabolism of inorganic arsenic (74As) in humans following oral ingestion. Toxicol Appl Pharmacol 1979; 50:319-22.
13. Buchet JP, Lauwerys R, Roels H. Comparison of the urinary excretion of arsenic metabolites after a single oral dose of sodium arsenite, monomethylarsonateordimethylarsinate in man. Int Arch Occup Environ Health 1981; 48:71-79.
14. American Conference of Governmental Industrial Hygienists (ACGIH). Threshold Limit Values for Chemical Substance and Physical Agents and Biological Exposure Indices, 1995-1996. Cincinnati, OH: ACGIH, 1995.
15. Levine L, Fahy JP. Evaluation of urinary lead determinations. I. The significance of the specific gravity. J Ind Hyg Toxicol 1945; 27:217-23.
16. Elkins HB, Pagnotto LD. Is the 24-hour urine sample a fallacy? Am Ind Hyg Assoc J 1965; 26:456-60.
17. Araki S, Sata F, Murata K. Adjustment for urinary flow rate: an improved approach to biological monitoring. Int Arch Occup Environ Health 1990; 62:471-77.
18. Greenberg GN, Levine RJ. Urinary creatinine excretion is not stable: a new method for assessing urinary toxic substance concentrations. J Occup Med 1989; 31:832-38.
19. Elkins HB, Ragnotto LD, Smith HL. Concentration adjustments in urinalysis. Am Ind Hyg Assoc J 1974; 35:559-65.
20. Araki S. Effects of urinary volume on urinary concentrations of lead, delta-aminolaevulinic acid, coproporphyrin, creatinine, and total solutes. Br J Ind Med 1980; 37:50-54.
21. Araki S, Murata K, Aono H, et al. Comparison of the effects of urinary flow on adjusted and non-adjusted excretion of heavy metals and organic substances in 'healthy' men. J Appl Toxicol 1986; 6:245-51.
22. Atlantic Richfield Co. Environmental Action Plan for the Upper Clark Fork River Basin, Summer 1993. Los Angeles, CA: Atlantic Richfield, 1993; ARCOD-6010-B.
23. Que Hee S, Peace B, Clark S, et al. Evolution of efficient methods to sample lead sources, such as house dust and hand dust, in the homes of children. Environ Res 1985; 38:77-95.
24. Walters NJ, Estridge BH, Reynolds AP. Basic Medical Laboratory Techniques. 2nd ed. Albany, NY: Delmar Publisher, 1990:309-10.
25. Henry RJ. Clinical Chemistry: Principles and Technique. 3rd ed. New York: Harper and Row, 1965.
26. Yamamoto M, Yasuda M, Yamamoto Y. Hydride-generation atomic absorption spectrometry coupled with flow injection analysis. Anal Chem 1985; 57:1382-85.
27. National Institute of Occupational Safety and Health (NIOSH). Arsenic in urine and air. In: NIOSH Manual of Analytical Methods. 2nd ed, vol 1. Cincinnati, OH: NIOSH, 1977; method no. P&CAM 139.
28. Norin H, Vahter M. A rapid method for the selective analysis of total urinary metabolites of inorganic arsenic. Scand J Work Environ Health 1981; 7:38-44.
29. Fox Software. FoxBASE+/Mac-Relational Database Management System. Perrysburg, OH: Fox Software; March 1991.
30. SAS. SAS/STAT User's Guide. Ver 6, 4th ed. Cary, NC: SAS Institute, 1989.
31. Slovis TL, Sty JR, Haller JO. Appendix 7: Glomerular Filtration Rate Using the Modified Gates Method-Normogram for the Determination of Body Surface Area of Children. Philadelphia, PA: WB Saunders, 1989; pp 58-59.
32. Binder S, Forney D, Kaye W, et al. Arsenic exposure in children living near a former copper smelter. Bull Environ Contam Toxicol 1987; 39:114-21.
33. Polissar L, Lowry-Coble K, Kalman DA, et al. Pathways of human exposure to arsenic in a community surrounding a copper smelter. Environ Res 1990; 53:29-47.
34. McVehil-Monnett Associates (MMA). Annual Aerometric Monitoring Report for the Anaconda Smelter Remedial Investigation/Feasibility Study Air Resources Program (July 1991-June 1992). Prepared for PTI Environmental Services and for ARCO Coal Company (MMA document control number 228-RI1-RT-AN92).
35. Davis A, Ruby MV, Drexier J. Mineralogical Constraints on the Bioavailability of Arsenic in Smelter Impacted Soils. Boulder, CO: PTI Environmental Services, 1993. Presented at the International Conference on Arsenic Exposure and Health Effects; New Orleans, LA, 1993.
36. Freeman GB, Johnson JD, Killinger JM, et al. Bioavailability of arsenic in soil impacted by smelter activities following oral administration in rabbits. Fund Appl Toxicol 1993; 21(1):83-88.
37. Lauwerys RR. Industrial chemical exposure: Guidelines for Biological Monitoring. Davis, CA: Biomedical Publications, 1983.
38. Boeniger MF, Lowry LK, Rosenberg J. Interpretation of urine results used to assess chemical exposure with emphasis on creatinine adjustments: a review. Am Ind Hyg Assoc J 1993; 54(10):615-27.